Literature DB >> 24941666

Topical capsaicin formulations in the management of neuropathic pain.

Mark Schumacher, George Pasvankas.   

Abstract

This chapter reviews the scientific and clinical evidence supporting the use of topical formulations containing the pungent principle of chili peppers--capsaicin, for the treatment of peripheral neuropathic pain. Given the limitations of current oral and parenteral therapies for the management of pain arising from various forms of nerve injury, alternate therapeutic approaches that are not associated with systemic adverse events that limit quality of life, impair function, or threaten respiratory depression are critically needed. Moreover, neuropathic conditions can be complicated by progressive changes in the central and peripheral nervous system, leading to persistent reorganization of pain pathways and chronic neuropathic pain. Recent advances in the use of high-dose topical capsaicin preparations hold promise in managing a wide range of painful conditions associated with peripheral neuropathies and may in fact help reduce suffering by reversing progressive changes in the nervous system associated with chronic neuropathic pain conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24941666     DOI: 10.1007/978-3-0348-0828-6_4

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  4 in total

1.  Preparation and Evaluation of PLGA-Coated Capsaicin Magnetic Nanoparticles.

Authors:  Mrudhula Baskaran; Padmamalini Baskaran; Navamoney Arulsamy; Baskaran Thyagarajan
Journal:  Pharm Res       Date:  2017-03-21       Impact factor: 4.200

Review 2.  ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.

Authors:  Ramona D'Amico; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

3.  Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist.

Authors:  Eva Uchytilova; Diana Spicarova; Jiri Palecek
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

4.  Evaluation of In Vitro Capsaicin Release and Antimicrobial Properties of Topical Pharmaceutical Formulation.

Authors:  Enkelejda Goci; Entela Haloci; Antonio Di Stefano; Annalisa Chiavaroli; Paola Angelini; Ajkuna Miha; Ivana Cacciatore; Lisa Marinelli
Journal:  Biomolecules       Date:  2021-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.